MIDLAND, MICH - February 22, 2007 -- Dowpharma today announced that Merck & Co., Inc. has entered into a multi-product commercial license agreement for Pfenex Expression Technology™, a Pseudomonas-based technology from Dowpharma.
MIDLAND, MICH - February 22, 2007 -- Dowpharma today announced that Merck & Co., Inc. has entered into a multi-product commercial license agreement for Pfenex Expression Technology™, a Pseudomonas-based technology from Dowpharma.
